Cell Reprogramming Requires Silencing of a Core Subset of Polycomb Targets
Giulia Fragola(European Institute of Oncology), Giuseppe Testa(Human Technopole), Alessandro Cuomo(European Institute of Oncology), Stefano Casola(IFOM), Pasquale Laise(Columbia University Irving Medical Center), Gabriele Bucci, Tiziana Bonaldi(University of Milan), E. Signaroldi(European Institute of Oncology), Gustavo Mostoslavsky(Boston University), Giancarlo Pruneri(University of Milan), Alessandro Blasimme(ETH Zurich), Pierre‐Luc Germain(University of Zurich), Fridolin Groß(European Institute of Oncology), Giovanni Mazzarol(European Institute of Oncology), Cesar Sommer(Allogene Therapeutics (United States))
Cited by 68
Related Papers
Explainability for artificial intelligence in healthcare: a multidisciplinary perspective
|BMC Medical Informatics and Decision Making|2020|1.8k
Regulation of the Germinal Center Response by MicroRNA-155
|Science|2007|1.5k
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
|Nature Immunology|2006|771